Literature DB >> 16968784

Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract.

Indira U Mysorekar1, Scott J Hultgren.   

Abstract

Recurrent urinary tract infections (rUTIs) are a source of considerable morbidity in women. The infecting bacteria in both rUTIs and a de novo acute infection have been thought to originate from an extraurinary location. Here, we show in a murine model of UTI that uropathogenic Escherichia coli (UPEC) established quiescent intracellular reservoirs (QIRs) in Lamp1+ endosomes within the urinary bladder epithelium. Depending on the integrity of the urothelial barriers at the time of initial infection, these QIRs were established within terminally differentiated superficial facet cells and/or underlying transitional epithelial cells. Treatment of infected bladders harboring exclusively superficial facet cell QIRs with the cationic protein, protamine sulfate, led to epithelial exfoliation and eradication of bacteria in 100% of treated animals. However, when the bacterial QIRs were harbored in underlying transitional cells, stimulation of epithelial turnover triggered reemergence of viable organisms and recurrence of infection. Thus, our results suggest (i) that bacterial QIRs within the bladder may be a previously unappreciated source of recurrent UTIs and (ii) that inducing epithelial exfoliation may be a therapeutic avenue for treating this heretofore recalcitrant disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16968784      PMCID: PMC1564066          DOI: 10.1073/pnas.0602136103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli.

Authors:  Indira U Mysorekar; Matthew A Mulvey; Scott J Hultgren; Jeffrey I Gordon
Journal:  J Biol Chem       Date:  2001-12-13       Impact factor: 5.157

2.  Disruption of bladder epithelium barrier function after spinal cord injury.

Authors:  Gerard Apodaca; Susanna Kiss; Wily Ruiz; Susan Meyers; Mark Zeidel; Lori Birder
Journal:  Am J Physiol Renal Physiol       Date:  2003-01-14

3.  Intracellular bacterial biofilm-like pods in urinary tract infections.

Authors:  Gregory G Anderson; Joseph J Palermo; Joel D Schilling; Robyn Roth; John Heuser; Scott J Hultgren
Journal:  Science       Date:  2003-07-04       Impact factor: 47.728

4.  Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.

Authors:  M A Mulvey; J D Schilling; S J Hultgren
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  Reversible inactivation of bladder surface glycosaminoglycan antibacterial activity by protamine sulfate.

Authors:  C L Parsons; C W Stauffer; J D Schmidt
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

6.  Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli.

Authors:  Joel D Schilling; Robin G Lorenz; Scott J Hultgren
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.

Authors:  S Langermann; R Möllby; J E Burlein; S R Palaszynski; C G Auguste; A DeFusco; R Strouse; M A Schenerman; S J Hultgren; J S Pinkner; J Winberg; L Guldevall; M Söderhäll; K Ishikawa; S Normark; S Koenig
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

Review 8.  The basis of persistent bacterial infections.

Authors:  Mikael Rhen; Sofia Eriksson; Mark Clements; Sven Bergström; Staffan J Normark
Journal:  Trends Microbiol       Date:  2003-02       Impact factor: 17.079

Review 9.  The etiology of urinary tract infection: traditional and emerging pathogens.

Authors:  Allan Ronald
Journal:  Dis Mon       Date:  2003-02       Impact factor: 3.800

Review 10.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.

Authors:  Betsy Foxman
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

View more
  202 in total

1.  Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Corinne K Cusumano; Thomas J Hannan; James W Janetka; Scott J Hultgren
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

2.  Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073.

Authors:  Luke P Allsopp; Christophe Beloin; Glen C Ulett; Jaione Valle; Makrina Totsika; Orla Sherlock; Jean-Marc Ghigo; Mark A Schembri
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 3.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 4.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

Review 5.  [Urinary tract immunology].

Authors:  S Schubert
Journal:  Urologe A       Date:  2010-05       Impact factor: 0.639

6.  Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.

Authors:  Matthew G Blango; Matthew A Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

7.  Ag43 promotes persistence of uropathogenic Escherichia coli isolates in the urinary tract.

Authors:  Petra Lüthje; Annelie Brauner
Journal:  J Clin Microbiol       Date:  2010-03-31       Impact factor: 5.948

8.  Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children.

Authors:  Luciana Robino; Paola Scavone; Lucia Araujo; Gabriela Algorta; Pablo Zunino; María Catalina Pírez; Rafael Vignoli
Journal:  Clin Infect Dis       Date:  2014-08-04       Impact factor: 9.079

9.  Persistence of uropathogenic Escherichia Coli in the bladders of female patients with sterile urine after antibiotic therapies.

Authors:  Shu-Cheng Liu; Xiao-Min Han; Ming Shi; Zi-Li Pang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

Review 10.  Urinary Tract Infection: Pathogenesis and Outlook.

Authors:  Lisa K McLellan; David A Hunstad
Journal:  Trends Mol Med       Date:  2016-09-28       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.